Central Line Infusion Ltd is categorized under Home Health Care Services in Amarillo, TX and active since 1994.
Central Line Infusion Ltd was established in 1994, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 621610 by the NAICS.
If you are seeking more information, feel free to contact Michael Swayden at the company’s single location by writing to 603 Quail Creek Drive # 700, Amarillo, Texas TX 79124 or by phoning (949) 273-6528. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Line Infusion Ltd |
| Contact Person: | Michael Swayden |
| Address: | 603 Quail Creek Drive # 700, Amarillo, Texas 79124 |
| Phone Number: | (949) 273-6528 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 621610 |
| Share This Business: |
Central Line Infusion Ltd was started in 1994 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 621610. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael Swayden for inquiries that concern Central Line Infusion Ltd by calling the company number (949) 273-6528, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Line Infusion Ltd can be found at the coordinates 35.210563,-101.910976 as well as the street address 603 Quail Creek Drive # 700 in Amarillo, Texas 79124.
For its online presence, you may visit Central Line Infusion Ltd’s website at and engage with its social media outlets through on Twitter and on Facebook.